INTERVIEW: Mylan set to rev up Indian ops but wants policy stability
This article was originally published in Scrip
Executive Summary
If plans outlined by the multinational generic company's president are anything to go by, Mylan appears set for a major expansion in India, boosted by its recent acquisition of local firm Agila Specialties, although it is maintaining a generally cautious stance over policy-related uncertainties in the country.